Cell line development is under constant pressure to become faster, more efficient and more reproducible. Leadgene Biosolutions specialises in this space, providing microbioreactor technology for early-stage cell culture, with a focus on improving process control and generating more informative data during CLD and bioprocess optimisation.

One of the most interesting takeaways from the recent Leadgene Biosolutions and NIBRT webinar was how relatively small changes at the earliest stages of cell culture can have a measurable impact on downstream workflows.

Key takeaways

1. Early introduction of gentle mixing can accelerate CLD workflows.

1. Independent testing by NIBRT showed faster scale-up than both static culture and shaker incubation.

1. Gentle mixing improved clone recovery and enabled higher cell densities during early-stage culture.

1. Real-time dissolved oxygen (DO) and pH monitoring provides valuable insight into culture performance throughout the process.

Independent validation stands out

A highlight of the webinar was NIBRT's independent evaluation of the technology. The study compared gentle mixing with conventional static culture and shaker incubation across multiple seeding densities within a real CLD workflow.

The results were compelling. Gentle mixing accelerated CLD by approximately five to seven days compared with traditional approaches, while also delivering higher clone recovery rates and allowing cultures to achieve greater cell densities before transferring to larger vessels. These improvements were observed consistently across the seeding densities evaluated, demonstrating the potential value of introducing mixing much earlier in the workflow.

Why does gentle mixing make a difference?

The webinar highlighted how introducing controlled mixing at the 96-well and 24-well plate stages improves oxygen transfer and creates a more homogeneous culture environment. Rather than waiting until cells reach larger vessels before introducing agitation, gentle mixing helps cells adapt earlier to suspension culture, supporting healthier growth and faster expansion.

Combined with real-time DO and pH monitoring, researchers also gain continuous insight into culture conditions without interrupting the experiment, providing additional information to support process development decisions.

Why this matters

For organisations developing biologics and advanced therapies, even modest reductions in development timelines can translate into significant improvements in laboratory productivity and resource utilisation.

The webinar reinforced that optimising early-stage culture conditions is not simply about growing cells faster. Better clone recovery, higher achievable cell densities and improved process insight all contribute to building more efficient and robust CLD workflows.

As suppliers of scientific equipment to the biotech and biopharma sectors, we always value seeing independent validation alongside technology innovation. NIBRT's evaluation provided practical evidence that gentle mixing can deliver measurable benefits in real laboratory workflows, making it one of the strongest and most valuable messages from the session.

Watch the full webinar here.